Insight

Vedang Murthy: Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Vedang Murthy/X

Jan 4, 2025, 16:23

Vedang Murthy: Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Vedang Murthy, Professor GU-Radiation Oncology at Tata Memorial Centre Mumbai, shared a post on X:

“With the new year, comes new insight.

Is 25Gy/5 enough for prophylactic nodal RT in high-risk Prostate Cancer?

Borrowed from rectal cancer protocols, it has never been validated for prostate SBRT—until now.

The SHARP consortium offers insights.”

Pelvic regional control with 25Gy in 5 fractions in SBRT for high risk prostate cancer: Pooled prospective outcomes from the SHARP consortium

Authors: Vedang Murthy, Indranil Mallick, Priyamvada Maitre, Gargee Mulye, Moses Arunsingh, Luca Valle, Michael Steinberg, Thomas Kennedy, Andrew Loblaw, Amar U Kishan.

Vedang Murthy

Amar U. Kishan Andrew Loblaw cancer Gargee Mulye Indranil Mallick Luca Valle Michael Steinberg Moses Arunsingh OncoDaily Oncology Priyamvada Maitre prostate cancer rectal cancer Thomas Kennedy Vedang Murthy

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!

Oncologist Near Me – Fedro Alessandro Peccatori: Leading Expert in Gynecological Oncology

MATTERHORN trial - FLOT plus durvalumab will become the new standard of care in the preoperative setting for gastroesophageal cancer

Daiichi Sankyo's and Astrazeneca's press release on ENHERTU®: Latest Updates from DESTINY-Gastric04 trial

13-year-old Cancer Survivor Sworn in as a Secret Service agent by President Trump - The White House